Stocks Whipsaw on Tariff Drama, Trump Loses Support on Wall St.
The Rundown
00:00
Market Turmoil and Pharmaceutical Gains Amid Tariff Tensions
This chapter examines the volatile stock market, particularly the rise in Teva pharmaceutical shares amidst FDA news, while Chinese companies face declines due to U.S. tariffs. It further explores CEO concerns regarding potential job cuts and a looming recession, painting a picture of economic uncertainty.
Transcript
Play full episode
